SV almost goes B(ust) 📉
from Healthtech Pigeon Hosted by SomX
This week: Jessica Smith is joined by James, Belle and Albion VC's Molly Gilmartin. [01:50] SVB fuelled high-risk, high-reward tech firms. Now health start-ups feel bereft [10:00] Why do so many biotechs face being kicked off the Nasdaq? [15:15] How UK healthtechs can get a head start on their US expansion [28:05] Why investors should pay close attention to the UK’s healthtech sector in 2023 ✍️ Apply to be a guest at this form 📖 Learn more about the SomX team at somx.health 🖇 Connect with Jessica on LinkedIn 🖇 Connect with James on LinkedIn 🖇 Connect with Belle on LinkedIn 🖇 Connect with Molly on LinkedIn
Embed this episode
No transcript yet.